Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen receptor target gene: an evolving concept.

Jason S Carroll1, Myles Brown

  • 1Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

Molecular Endocrinology (Baltimore, Md.)
|January 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistance.

Genome medicine·2026
Same author

CistromeMeta: a large language model powered tool for automated ChIP-seq metadata extraction.

Bioinformatics (Oxford, England)·2026
Same author

Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment.

Theranostics·2026
Same author

Towards the targeted protein degradation of CK2: design and synthesis of CAM4066-based PROTACs.

Beilstein journal of organic chemistry·2026
Same author

Genomic and spatial analysis of local recurrences following risk-adapted breast radiotherapy in the IMPORT trials.

Breast cancer research : BCR·2026
Same author

Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Editorial Reflections on the Demise of Molecular Endocrinology and the Future of Molecular Hormone Action Research.

Molecular endocrinology (Baltimore, Md.)·2016
Same journal

Origins of the Field of Molecular Endocrinology: A Personal Perspective.

Molecular endocrinology (Baltimore, Md.)·2016
Same journal

Bidding a Fond Farwell to Molecular Endocrinology.

Molecular endocrinology (Baltimore, Md.)·2016
Same journal

Editorial: Centennial Celebration - An Interview With Professor Evan Simpson on Hormones and Cancer.

Molecular endocrinology (Baltimore, Md.)·2016
Same journal

Editorial: Reflections on the Impact of Molecular Endocrinology on a Scientific Career.

Molecular endocrinology (Baltimore, Md.)·2016
Same journal

Reflections on the Merger of Molecular Endocrinology and Endocrinology.

Molecular endocrinology (Baltimore, Md.)·2016
See all related articles

Estrogen receptor (ER) binds to DNA via distal enhancer elements, guided by the pioneer factor FoxA1, to regulate gene expression driving breast cancer progression. Understanding these cis-regulatory elements enhances knowledge of ER activity and potential drug targets.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Estrogen receptor (ER) is a transcription factor crucial for cell division and breast cancer progression.
  • While ER gene targets and cofactors are studied, cis-regulatory elements remain poorly understood.

Purpose of the Study:

  • To review technological advances for understanding ER target genes.
  • To explore cis-regulatory domains that enhance ER target gene transcription.

Main Methods:

  • Review of recent scientific literature on ER function and technology.
  • Analysis of studies identifying ER genomic recruitment mechanisms.

Main Results:

  • ER genomic recruitment is mediated by the pioneer factor FoxA1.

Related Experiment Videos

  • ER associates with distal enhancer elements, not promoter-proximal regions.
  • These enhancers tether the ER complex to target gene promoters.

    • Conclusions:

    • Technological advancements enable detailed investigation of ER activity.
    • Understanding ER cis-regulatory elements may lead to improved breast cancer therapies.